Member, National Dialogue on Cancer (1998 to 2005); Coordinator of NDC Cancer Control Teams (2000); Member, Structure and Governance Task Force (2000); Member, Quality Cancer Care Team (2000); Member, Clinical Research Task Force (2001 to 2004).

Member, Executive Board, National Patient Advocacy Foundation and Patient Advocacy Foundation (2002 to 2005); Member, Policy Board; Member, Strategic Planning Committee

Member,  National Cancer Institute FLAIR grant review panel (2002)

Chairman, National Advisory Board, Ortho Biotech (1997 to 2001)

Chairman, Oncology Advisory Board, Novartis (1998 to 2001)

Member, Oncology Advisory Board, Glaxo Wellcome, (1998)

Member, American Cancer Society, National Task Force to Identify a Recommended Benefits Package for Oncologic Services; Member, Summary Document Writing Sub-Group; Member, Suppliers of Oncologic Care Sub-Group; (1997)

Liaison, Joint Commission on Accreditation of Healthcare Organizations (JCAHO), for the Association of Community Cancer Centers (1992 to 2004)

Member,  American College of Surgeons, National Clinical Data Base Committee on Data Management (1989 to 1991)

Member, Health Care Financing Administration Research and Demonstration Grants Review Panels (1981 to 1991)

Member, DHHS Commission on DRGs and Clinical Research.  Appointed by Secretary of DHHS to a 10‑member panel to research impact of DRGs on clinical research.  Panel members include Assistant Secretary of Health, Director of NIH, Administrator of HCFA, Director of NCI, and representatives from AMA, AHA, AAMC (1982).

Medal of Honor Awardee, USON award for outstanding contributions to quality cancer care (2002)

Honorary National Membership Award, Oncology Nursing Society (2002)